Clinical Site

San Diego, California 92123

2 studies enrolling now · 14 studies all time

What they study most

Arthritis, Psoriatic, Bipolar Depression, Generalized Anxiety Disorder, Hidradenitis Suppurativa, In-situ Small Bowel T-cell Lymphoma, Major Depressive Disorder, Psychosis Associated With Alzheimer's Disease, Respiratory Syncytial Virus Infections, Schizophrenia, Type II Refractory Celiac Disease (RCD-II)

Studies at this site

• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis — Recruiting now
• Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response — Recruiting now
• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug — Running, not enrolling
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia — Completed
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression — Completed
• A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment — Completed
• A Trial to Assess the Antipsychotic Efficacy of ITI-007 — Completed
• Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression — Completed
• Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease — Completed
• Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed